HUNTINGTON NATIONAL BANK - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48,511
-1.5%
6,852
-2.0%
0.00%
Q2 2023$49,238
-11.7%
6,994
+4.7%
0.00%
-100.0%
Q1 2023$55,736
-12.4%
6,683
+20.6%
0.00%0.0%
Q4 2022$63,634
-9.1%
5,543
-0.7%
0.00%0.0%
Q3 2022$70,000
+45.8%
5,582
+24.0%
0.00%0.0%
Q2 2022$48,000
-34.2%
4,5010.0%0.00%0.0%
Q1 2022$73,000
+17.7%
4,5010.0%0.00%0.0%
Q4 2021$62,000
-4.6%
4,5010.0%0.00%0.0%
Q3 2021$65,000
-8.5%
4,5010.0%0.00%0.0%
Q2 2021$71,000
+54.3%
4,5010.0%0.00%0.0%
Q1 2021$46,000
+35.3%
4,5010.0%0.00%
Q4 2020$34,000
+126.7%
4,5010.0%0.00%
Q3 2020$15,000
-28.6%
4,5010.0%0.00%
Q2 2020$21,000
+133.3%
4,5010.0%0.00%
Q1 2020$9,000
-43.8%
4,5010.0%0.00%
Q4 2019$16,000
+23.1%
4,5010.0%0.00%
Q3 2019$13,000
-23.5%
4,5010.0%0.00%
Q2 2019$17,000
-54.1%
4,501
+0.0%
0.00%
-100.0%
Q1 2019$37,000
+2.8%
4,500
-0.0%
0.00%0.0%
Q4 2018$36,000
+5.9%
4,5010.0%0.00%0.0%
Q3 2018$34,000
+30.8%
4,501
+0.0%
0.00%
Q2 2018$26,0004,5000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 7,637,700$77,675,0007.44%
Burrage Capital Management LLC 864,916$8,796,0007.13%
ORACLE INVESTMENT MANAGEMENT INC 2,367,670$24,079,0003.61%
HealthCor Management, L.P. 4,886,440$49,695,0001.76%
Ghost Tree Capital, LLC 500,000$5,085,0001.20%
Integral Health Asset Management, LLC 400,000$4,068,0001.16%
Lisanti Capital Growth, LLC 472,520$4,806,0000.62%
Parkman Healthcare Partners LLC 244,680$2,488,0000.58%
Baker Brothers Advisors 12,710,818$129,269,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,605,380$26,497,0000.56%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders